N,N-bis(hydroxyethyl)-p-phenylenediamine 5 sulfate salt |
1984 |
≤5 |
264 |
reduced body weight; darkened thyroid glands; decreased serum
iron concentration; delayed hypersensitivity; allergic contact dermatitis |
no evidence |
(10) |
N-phenyl-p-phenylenediamine 4, N-phenyl-p-phenylenediamine
HCl |
1993 |
≤1.7 |
464–1000 |
reduced body weight; degenerated seminiferous tubules; skeletal
malformations; skin irritation |
no evidence |
(11) |
hydroxypropyl bis(N-hydroxyethyl-p-phenylenediamine) 6 HCl |
NA |
≤0.4 |
2186 |
reduced body weight, mean serum glucose and total protein levels;
reproductive and developmental toxicity |
no evidence |
(12) |
4-methoxy-m-phenylenediamine 8, 4-methoxy-m-phenylenediamine sulfate salt, 4-methoxy-m-phenylenediamine HCl |
1978 |
NA |
400–500 |
skin irritation; mutagenicity |
animal carcinogenicity |
(13) |
2-chloro-p-phenylenediamine 7, 2-chloro-p-phenylenediamine sulfate salt |
1984 |
≤1.0 |
NA |
skin irritation; reduced body weight;
ocular irritation |
no evidence |
(14) |
2-methyl-5-hydroxyethylaminophenol 10
|
NA |
≤5 |
5700 |
skin irritation; mutagenicity; allergic
contact dermatitis |
no evidence |
(15) |
p-methylaminophenol 9 sulfate
salt |
NA |
≤1 |
NA |
increased rate of formation of methemoglobin;
skin irritation |
no evidence |
(16) |
2,4-diaminophenol 11, 2,4-diaminophenol dihydrochloride
salt |
1993 |
≤0.2 |
240 |
skin irritation; severe ocular irritation;
mutagenicity |
no evidence |
(17) |
hydroquinone 12
|
1981 |
≤1 |
627–743 |
nephrotoxicity; cytotoxicity; skin irritation; skin
sensitization;
skin depigmentation; mutagenicity |
animal carcinogenicity |
(18, 19) |
t-butyl hydroquinone 13
|
1981 |
≤0.1 |
480–800 |
reduced body weights; mutagenicity |
no evidence |
(20) |
toluene-2,5-diamine 14, toluene-2,5-diamine
sulfate
salt |
1984 |
≤4 |
98–102 |
skin irritation; skin sensitization; ocular irritation; reproductive
toxicity; skeletal malformation |
no evidence |
(21−23) |
toluene-3,4-diamine 15
|
1984 |
NA |
NA |
duodenal lesions; genotoxicity; skin sensitization |
no evidence |
(21, 22) |
Disperse Blue 7 16
|
2002 |
NA |
NA |
mutagenicity |
no evidence |
(24) |
Disperse Violet 1 17
|
1988 |
≤1 |
NA |
ocular irritation |
no
evidence |
(25) |
Disperse Yellow 3 18
|
1992 |
NA |
NA |
nephrotoxicity;
chromosomal aberrations; allergic contact dermatitis |
animal carcinogenicity |
(26) |
Acid Violet 43 19
|
1984 |
≤1 |
NA |
no significant toxicity |
no evidence |
(27) |
Basic Blue 99 20
|
1992 |
≤2 |
>2000 |
skin irritation |
no evidence |
(28) |
HC Blue no. 2 21
|
1993 |
≤1.7 |
1250–5000 |
mutagenicity |
no evidence |
(29) |
HC Yellow no. 5 22
|
2002 |
≤1.6 |
555.56 |
skin irritation |
no evidence |
(30) |
HC Red no. 7 23
|
2005 |
≤1 |
NA |
skin sensitization;
mutagenicity |
no evidence |
(31) |